RT Journal Article SR Electronic T1 Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune checkpoint CD200 JF Journal for ImmunoTherapy of Cancer JO J Immunother Cancer FD BMJ Publishing Group Ltd SP 227 DO 10.1186/s40425-019-0710-1 VO 7 IS 1 A1 Mahadevan, Daruka A1 Lanasa, Mark C. A1 Farber, Charles A1 Pandey, Manjari A1 Whelden, Maria A1 Faas, Susan J. A1 Ulery, Terrie A1 Kukreja, Anjli A1 Li, Lan A1 Bedrosian, Camille L. A1 Zhang, Xiaoping A1 Heffner, Leonard T. YR 2019 UL http://jitc.bmj.com/content/7/1/227.abstract AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.